These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 37940895)

  • 1. Comparative diagnostic accuracy of the IOTA SRR and LR2 scoring systems for discriminating between malignant and Benign Adnexal masses by junior physicians in Chinese patients: a retrospective observational study.
    Tian C; Wen SB; Zhao CY; Yan XN; Du JX
    BMC Womens Health; 2023 Nov; 23(1):585. PubMed ID: 37940895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective external validation of IOTA methods for classifying adnexal masses and retrospective assessment of two-step strategy using benign descriptors and ADNEX model: Portuguese multicenter study.
    Borges AL; Brito M; Ambrósio P; Condeço R; Pinto P; Ambrósio B; Mahomed F; Gama JMR; Bernardo MJ; Gouveia AI; Djokovic D
    Ultrasound Obstet Gynecol; 2024 Oct; 64(4):538-549. PubMed ID: 38477149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound-based logistic regression model LR2 versus magnetic resonance imaging for discriminating between benign and malignant adnexal masses: a prospective study.
    Shimada K; Matsumoto K; Mimura T; Ishikawa T; Munechika J; Ohgiya Y; Kushima M; Hirose Y; Asami Y; Iitsuka C; Miyamoto S; Onuki M; Tsunoda H; Matsuoka R; Ichizuka K; Sekizawa A
    Int J Clin Oncol; 2018 Jun; 23(3):514-521. PubMed ID: 29236181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lesion size affects diagnostic performance of IOTA logistic regression models, IOTA simple rules and risk of malignancy index in discriminating between benign and malignant adnexal masses.
    Di Legge A; Testa AC; Ameye L; Van Calster B; Lissoni AA; Leone FP; Savelli L; Franchi D; Czekierdowski A; Trio D; Van Holsbeke C; Ferrazzi E; Scambia G; Timmerman D; Valentin L
    Ultrasound Obstet Gynecol; 2012 Sep; 40(3):345-54. PubMed ID: 22611001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of IOTA Simple Rules, Simple Rules risk assessment, ADNEX model and O-RADS in differentiating between benign and malignant adnexal lesions in North American women.
    Hiett AK; Sonek JD; Guy M; Reid TJ
    Ultrasound Obstet Gynecol; 2022 May; 59(5):668-676. PubMed ID: 34533862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of IOTA three-step strategy and logistic regression model LR2 for discriminating between benign and malignant adnexal masses.
    Hidalgo JJ; Llueca A; Zolfaroli I; Veiga N; Ortiz E; Alcázar JL
    Med Ultrason; 2021 May; 23(2):168-175. PubMed ID: 33626112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective external validation of IOTA three-step strategy for characterizing and classifying adnexal masses and retrospective assessment of alternative two-step strategy using simple-rules risk.
    Hidalgo JJ; Ros F; Aubá M; Errasti T; Olartecoechea B; Ruiz-Zambrana Á; Alcázar JL
    Ultrasound Obstet Gynecol; 2019 May; 53(5):693-700. PubMed ID: 30353585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of diagnostic efficiency between IOTA LR2 model and doctors
    Zhao B; Fu Y; Wen L; Wang Z; Fu C; Liu M
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 47(8):1082-1088. PubMed ID: 36097776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of IOTA ADNEX model in evaluating adnexal masses in a gynecological oncology center in China.
    Chen H; Qian L; Jiang M; Du Q; Yuan F; Feng W
    Ultrasound Obstet Gynecol; 2019 Dec; 54(6):815-822. PubMed ID: 31152572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving diagnostic strategies for ovarian cancer in Filipino women using ultrasound imaging and a multivariate index assay.
    Velayo CL; Reforma KN; Sicam RVG; Diwa MH; Sy ADR; Tantengco OAG
    Cancer Epidemiol; 2022 Dec; 81():102253. PubMed ID: 36179631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating risk of malignancy in adnexal masses: external validation of the ADNEX model and comparison with other frequently used ultrasound methods.
    Meys EMJ; Jeelof LS; Achten NMJ; Slangen BFM; Lambrechts S; Kruitwagen RFPM; Van Gorp T
    Ultrasound Obstet Gynecol; 2017 Jun; 49(6):784-792. PubMed ID: 27514486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. External validation of IOTA simple descriptors and simple rules for classifying adnexal masses.
    Alcázar JL; Pascual MA; Graupera B; Aubá M; Errasti T; Olartecoechea B; Ruiz-Zambrana A; Hereter L; Ajossa S; Guerriero S
    Ultrasound Obstet Gynecol; 2016 Sep; 48(3):397-402. PubMed ID: 26748432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of ADNEX and IOTA two-step strategy and estimation of risk of complications during follow-up of adnexal masses in low-risk population.
    Pascual MA; Vancraeynest L; Timmerman S; Ceusters J; Ledger A; Graupera B; Rodriguez I; Valero B; Landolfo C; Testa AC; Bourne T; Timmerman D; Valentin L; Van Calster B; Froyman W
    Ultrasound Obstet Gynecol; 2024 Sep; 64(3):395-404. PubMed ID: 38477179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presurgical diagnosis of adnexal tumours using mathematical models and scoring systems: a systematic review and meta-analysis.
    Kaijser J; Sayasneh A; Van Hoorde K; Ghaem-Maghami S; Bourne T; Timmerman D; Van Calster B
    Hum Reprod Update; 2014; 20(3):449-62. PubMed ID: 24327552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Performance of Ultrasonography-Based Risk Models in Differentiating Between Benign and Malignant Ovarian Tumors in a US Cohort.
    Yoeli-Bik R; Longman RE; Wroblewski K; Weigert M; Abramowicz JS; Lengyel E
    JAMA Netw Open; 2023 Jul; 6(7):e2323289. PubMed ID: 37440228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective evaluation of IOTA logistic regression models LR1 and LR2 in comparison with subjective pattern recognition for diagnosis of ovarian cancer in an outpatient setting.
    Nunes N; Ambler G; Foo X; Widschwendter M; Jurkovic D
    Ultrasound Obstet Gynecol; 2018 Jun; 51(6):829-835. PubMed ID: 28976616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the diagnostic accuracy of International Ovarian Tumor Analysis simple rules and the risk of malignancy index to discriminate between benign and malignant adnexal masses.
    Auekitrungrueng R; Tinnangwattana D; Tantipalakorn C; Charoenratana C; Lerthiranwong T; Wanapirak C; Tongsong T
    Int J Gynaecol Obstet; 2019 Sep; 146(3):364-369. PubMed ID: 31206642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective evaluation of the IOTA logistic regression model LR2 for the diagnosis of ovarian cancer.
    Nunes N; Yazbek J; Ambler G; Hoo W; Naftalin J; Jurkovic D
    Ultrasound Obstet Gynecol; 2012 Sep; 40(3):355-9. PubMed ID: 22223587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra- and interobserver agreement when describing adnexal masses using the International Ovarian Tumor Analysis terms and definitions: a study on three-dimensional ultrasound volumes.
    Sladkevicius P; Valentin L
    Ultrasound Obstet Gynecol; 2013 Mar; 41(3):318-27. PubMed ID: 22915506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian cancer prediction in adnexal masses using ultrasound-based logistic regression models: a temporal and external validation study by the IOTA group.
    Timmerman D; Van Calster B; Testa AC; Guerriero S; Fischerova D; Lissoni AA; Van Holsbeke C; Fruscio R; Czekierdowski A; Jurkovic D; Savelli L; Vergote I; Bourne T; Van Huffel S; Valentin L
    Ultrasound Obstet Gynecol; 2010 Aug; 36(2):226-34. PubMed ID: 20455203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.